Fair Value Disclosures [Abstract]
Fair value measurements
Fair Value Disclosures [Text Block]
Commitments and Contingencies Disclosure [Abstract]
Litigation
Legal Matters and Contingencies [Text Block]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Expense included in earnings
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
Milestone achievement - asset acquisition
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases
Measurement period adjustment
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Measurement Period Adjustment
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Measurement Period Adjustment
Settlements
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements
Additions due to acquisition
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases
Balance, end of period
Stockholders' Equity Note [Abstract]
Stockholders' equity
Stockholders' Equity Note Disclosure [Text Block]
Revenue from Contract with Customer [Abstract]
Summary of Disaggregation of Revenue
Disaggregation of Revenue [Table Text Block]
Summary of Deferred Revenue Contract Liabilities
Contract with Customer, Asset and Liability [Table Text Block]
Schedule of Accounts Receivable, Net
Schedule of Accounts Receivable, Net [Table Text Block]
Schedule of Accounts Receivable, Net [Table Text Block]
Retirement Benefits [Abstract]
2020
Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months
2021
Defined Benefit Plan, Expected Future Benefit Payment, Year Two
2022
Defined Benefit Plan, Expected Future Benefit Payment, Year Three
2023
Defined Benefit Plan, Expected Future Benefit Payment, Year Four
2024
Defined Benefit Plan, Expected Future Benefit Payment, Year Five
Thereafter
Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter
Total
Defined Benefit Plan, Expected Future Benefit Payment, Remainder of Fiscal Year
Schedule of Share-based Payment Award, Valuation Assumptions, Stock Options Granted
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Summary of Stock Option Award Activity
Share-based Compensation, Stock Options, Activity [Table Text Block]
Summary of Restricted Stock Unit Award Activity
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
Summary of Stock-Based Compensation Expense
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]
Schedule of Accumulated Other Comprehensive Income (Loss)
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)
Preferred Stock, Par or Stated Value Per Share
Preferred stock, shares authorized (in shares)
Preferred Stock, Shares Authorized
Preferred stock, shares issued (in shares)
Preferred Stock, Shares Issued
Preferred stock, shares outstanding (in shares)
Preferred Stock, Shares Outstanding
Common stock, par value (in dollars per share)
Common Stock, Par or Stated Value Per Share
Common stock, shares authorized (in shares)
Common Stock, Shares Authorized
Common stock, shares issued (in shares)
Common Stock, Shares, Issued
Common stock, shares outstanding (in shares)
Common Stock, Shares, Outstanding
Treasury stock (in shares)
Treasury Stock, Shares
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table]
Schedule of Segment Reporting Information, by Segment [Table]
Concentration Risk Benchmark [Axis]
Concentration Risk Benchmark [Axis]
Concentration Risk Benchmark [Domain]
Concentration Risk Benchmark [Domain]
Sales Revenue, Product Line
Sales Revenue, Product Line [Member]
Product and Service [Axis]
Product and Service [Axis]
Product and Service [Domain]
Product and Service [Domain]
Anthrax Vaccines
Biothrax [Member]
Refers to NuThrax which is sold by the company.
ACAM2000
ACAM2000 [Member]
Business acquisition in October of 2017.
NARCAN Nasal Spray
NARCAN Nasal Spray [Member]
NARCAN Nasal Spray [Member]
Other
Other [Member]
Refers to product sales from other products.
Segment Reporting Information [Line Items]
Segment Reporting Information [Line Items]
Concentration risk percentage
Concentration Risk, Percentage
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]
Income Statement Location [Axis]
Income Statement Location [Axis]
Income Statement Location [Domain]
Income Statement Location [Domain]
Cost of product sales
Cost of Sales [Member]
Research and development
Research and Development Expense [Member]
Selling, general and administrative
Selling, General and Administrative Expenses [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense
Allocated Share-based Compensation Expense
Accounting Policies [Abstract]
Schedule of Long-term Debt Instruments [Table]
Schedule of Long-term Debt Instruments [Table]
Debt Instrument [Axis]
Debt Instrument [Axis]
Debt Instrument, Name [Domain]
Debt Instrument, Name [Domain]
2.875% Convertible Senior Notes Due 2021
Convertible Senior Notes Due 2021 [Member]
Convertible Senior Notes Due 2021 [Member]
Long-Term Debt [Line Items]
Debt Instrument [Line Items]
Interest rate, stated percentage
Debt Instrument, Interest Rate, Stated Percentage
Shares of common stock due to conversions (in shares)
Stock Issued During Period, Shares, Conversion of Convertible Securities
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities Disclosures [Table]
Derivative Instruments and Hedging Activities Disclosures [Table]
Derivative Instrument [Axis]
Derivative Instrument [Axis]
Derivative Contract [Domain]
Derivative Contract [Domain]
Interest Rate Swaps
Interest Rate Swap [Member]
Hedging Designation [Axis]
Hedging Designation [Axis]
Hedging Designation [Domain]
Hedging Designation [Domain]
Designated as Hedging Instrument
Designated as Hedging Instrument [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of Instruments
Number of Interest Rate Derivatives Held
Notional amount
Derivative, Notional Amount
Leases [Abstract]
Lessee, Lease, Description [Table]
Lessee, Lease, Description [Table]
Balance Sheet Location [Axis]
Balance Sheet Location [Axis]
Balance Sheet Location [Domain]
Balance Sheet Location [Domain]
Other Assets
Other Assets [Member]
Other current liabilities
Other Current Liabilities [Member]
Other Liabilities
Other Liabilities [Member]
Lessee, Lease, Description [Line Items]
Lessee, Lease, Description [Line Items]
Operating lease right-of-use assets
Operating Lease, Right-of-Use Asset
Operating lease liabilities, current portion
Operating Lease, Other Liability, Current
Operating Lease, Other Liability, Current
Operating lease liabilities
Operating Lease, Liability, Current
Total operating lease liabilities
Operating Lease, Liability
Operating leases:
Lease, Cost [Abstract]
Weighted average remaining lease term (years)
Operating Lease, Weighted Average Remaining Lease Term
Weighted average discount rate
Operating Lease, Weighted Average Discount Rate, Percent
Range [Axis]
Range [Axis]
Range [Domain]
Range [Domain]
Minimum
Minimum [Member]
Maximum
Maximum [Member]
Operating lease, term of contract
Lessee, Operating Lease, Term of Contract
Operating lease, renewal term
Lessee, Operating Lease, Renewal Term
Operating lease, termination period
Lessee, Operating Lease, Termination Period
Lessee, Operating Lease, Termination Period
Fair Value Measurements, Recurring and Nonrecurring [Table]
Fair Value Measurements, Recurring and Nonrecurring [Table]
Cash and Cash Equivalents [Axis]
Cash and Cash Equivalents [Axis]
Cash and Cash Equivalents [Domain]
Cash and Cash Equivalents [Domain]
Money Market Funds
Money Market Funds [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value Hierarchy and NAV [Axis]
Fair Value Hierarchy and NAV [Domain]
Fair Value Hierarchy and NAV [Domain]
Fair Value, Inputs, Level 1
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash held in money market accounts
Cash and Cash Equivalents, Fair Value Disclosure
Income Tax Disclosure [Abstract]
Income taxes
Income Tax Disclosure [Text Block]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of categories of public health threats
Number Of Categories Of Public Health Threats
Refers to the number of categories of public health threats.
Number of revenue generating products
Number Of Revenue Generating Products
Refers to the number of revenue generating products.
Number of operating segments
Number of Operating Segments
Earnings Per Share [Abstract]
Schedule of Net Income Per Share, Basic and Diluted
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Property Plant and Equipment Income Statement Disclosures [Abstract]
Schedule of Property, Plant and Equipment
Property, Plant and Equipment [Table Text Block]
Business Combinations [Abstract]
Schedule of Business Acquisitions, by Acquisition [Table]
Schedule of Business Acquisitions, by Acquisition [Table]
Finite-Lived Intangible Assets by Major Class [Axis]
Finite-Lived Intangible Assets by Major Class [Axis]
Finite-Lived Intangible Assets, Major Class Name [Domain]
Finite-Lived Intangible Assets, Major Class Name [Domain]
In Process Research and Development
In Process Research and Development [Member]
Restatement [Axis]
Restatement [Axis]
Restatement [Domain]
Restatement [Domain]
Previously Reported
Previously Reported [Member]
Business Acquisition [Axis]
Business Acquisition [Axis]
Business Acquisition, Acquiree [Domain]
Business Acquisition, Acquiree [Domain]
Adapt Pharma
Adapt Pharma [Member]
Business acquisition on October 15, 2018.
Business Acquisition [Line Items]
Business Acquisition [Line Items]
Fair value of tangible assets acquired and liabilities assumed:
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]
Cash
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents
Accounts receivable
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables
Inventory
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory
Prepaid expenses and other assets
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets
Accounts payable
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable
Accrued expenses and other liabilities
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Expenses and Other Liabilities
Amount of accrued expenses and other liabilities, assumed at the acquisition date.
Deferred tax liability, net
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities
Total fair value of tangible assets acquired and liabilities assumed
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net
Acquired in-process research and development
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles
Acquired intangible asset
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill
Goodwill
Goodwill
Total purchase price
Business Combination, Consideration Transferred
Measurement Period Adjustments
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments [Abstract]
Prepaid expenses and other assets, measurements period adjustments
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Prepaid Expenses and Other Assets
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Prepaid Expenses and Other Assets
Deferred tax liability, net, measurement period adjustments
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liabilities
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liabilities
Total fair value of tangible assets acquired and liabilities assumed, measurement period adjustments
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments Related to Previous Period
Measurement period adjustments
Goodwill, Purchase Accounting Adjustments
Total purchase price
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred
Revenue recognition
Revenue from Contract with Customer [Text Block]
Net actuarial loss
Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax
Prior service cost
Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax
Total recognized in accumulated other comprehensive loss
Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax
Accounts receivable [Abstract]
Accounts Receivable, Net [Abstract]
Billed, net
Billed Contracts Receivable
Unbilled
Unbilled Contracts Receivable
Total, net
Accounts Receivable, Net, Current
Business Combination, Consideration Transferred [Abstract]
Business Combination, Consideration Transferred [Abstract]
Amount of cash paid
Payments to Acquire Businesses, Gross
Fair value of contingent purchase consideration
Business Combination, Contingent Consideration, Liability
Fair value of tangible assets acquired:
Property, plant and equipment
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment
Acquired intangible assets
Schedule of Business Acquisitions, by Acquisition
Schedule of Business Acquisitions, by Acquisition [Table Text Block]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]
New Accounting Pronouncements or Change in Accounting Principle [Table]
New Accounting Pronouncements or Change in Accounting Principle [Table]
Equity Components [Axis]
Equity Components [Axis]
Equity Component [Domain]
Equity Component [Domain]
Retained Earnings
Retained Earnings [Member]
Initial Application Period Cumulative Effect Transition [Axis]
Initial Application Period Cumulative Effect Transition [Axis]
Initial Application Period Cumulative Effect Transition [Domain]
Initial Application Period Cumulative Effect Transition [Domain]
Difference between Revenue Guidance in Effect before and after Topic 606
Difference between Revenue Guidance in Effect before and after Topic 606 [Member]
Adjustments for New Accounting Pronouncements [Axis]
Adjustments for New Accounting Pronouncements [Axis]
Type of Adoption [Domain]
Type of Adoption [Domain]
Accounting Standards Update 2016-02
Accounting Standards Update 2016-02 [Member]
Accounting Standards Update 2014-09
Accounting Standards Update 2014-09 [Member]
Research and Development Arrangement, Contract to Perform for Others, Type [Axis]
Research and Development Arrangement, Contract to Perform for Others, Type [Axis]
Research and Development Arrangement, Contract to Perform for Others, Type [Domain]
Research and Development Arrangement, Contract to Perform for Others, Type [Domain]
CIADM
CIADM [Member]
Refers to the Center for Innovation in Advanced Development and Manufacturing contract.
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease, liability
Adoption of new accounting standard (ASC 606), net of tax
Cumulative Effect of New Accounting Principle in Period of Adoption
Base period
Base Period
Refers to the base period of contract term.
Term of contract
Term of Contract
Refers to the term of contract with BARDA.
Number of additional option periods
Number of Additional Option Periods
Refers to the number of additional option periods.
Contract liability
Contract with Customer, Liability
Deferred tax assets
Deferred Tax Assets, Net of Valuation Allowance
Pension expense
Pension Cost (Reversal of Cost)
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets, beginning of year
Defined Benefit Plan, Plan Assets, Amount
Acquisitions
Defined Benefit Plan, Plan Assets, Business Combination
Employer contributions
Defined Benefit Plan, Plan Assets, Contributions by Employer
Employee contributions
Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant
Net benefits received (paid)
Defined Benefit Plan, Plan Assets, Benefits Paid
Actual return on plan assets
Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)
Settlements
Defined Benefit Plan, Plan Assets, Payment for Settlement
Currency impact
Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)
Fair value of plan assets, end of year
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Projected benefit obligation, beginning of year
Defined Benefit Plan, Benefit Obligation
Acquisitions
Defined Benefit Plan, Benefit Obligation, Business Combination
Service cost
Defined Benefit Plan, Service Cost
Interest Cost
Defined Benefit Plan, Interest Cost
Employee contributions
Defined Benefit Plan, Plan Assets, Contributions by Employee
Amount of contribution received by defined benefit plan from employee which increases plan assets.
Actuarial loss
Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)
Net benefits received (paid)
Defined Benefit Plan, Benefit Obligation, Benefits Paid
Plan amendment
Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment
Settlements
Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement
Currency impact
Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)
Projected benefit obligation, end of year
Funded status, end of year
Defined Benefit Plan, Funded (Unfunded) Status of Plan
Accumulated benefit obligation, end of year
Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax
Derivative Instruments
Derivative Instruments and Hedging Activities Disclosure [Text Block]
Summary of Funded Status of the Swiss Plan
Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block]
Components of Net Periodic Pension Cost
Schedule of Net Benefit Costs [Table Text Block]
Schedule of Weighted Average Assumptions
Schedule of Assumptions Used [Table Text Block]
Schedule of Accumulated Other Comprehensive Loss Before Income Tax
Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]
Schedule of Expected Future Benefits Payments
Schedule of Expected Benefit Payments [Table Text Block]
Property, plant and equipment
Property, Plant and Equipment Disclosure [Text Block]
Inventory Disclosure [Abstract]
Raw materials and supplies
Inventory, Raw Materials and Supplies, Net of Reserves
Work-in-process
Inventory, Work in Process, Net of Reserves
Finished goods
Inventory, Finished Goods, Net of Reserves
Total inventories
Inventory, Net
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Table]
Total
AOCI Attributable to Parent [Member]
Defined Benefit Pension Plan
Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]
Derivative Instruments
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]
Derivative Instruments
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]
Foreign Currency Translation Losses
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss) [Line Items]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance
Stockholders' Equity Attributable to Parent
Other comprehensive income (loss)
OCI, before Reclassifications, Net of Tax, Attributable to Parent
Amounts reclassified from accumulated other comprehensive income
Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent
Total other comprehensive income (loss), net of tax
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Ending balance
Tax Credit Carryforward [Table]
Tax Credit Carryforward [Table]
Income Tax Authority [Axis]
Income Tax Authority [Axis]
Income Tax Authority [Domain]
Income Tax Authority [Domain]
Domestic Tax Authority
Domestic Tax Authority [Member]
State and Local Jurisdiction
State and Local Jurisdiction [Member]
Tax Credit Carryforward [Line Items]
Tax Credit Carryforward [Line Items]
Federal losses carryforward
Deferred Tax Assets, Operating Loss Carryforwards, Domestic
State losses carryforward
Deferred Tax Assets, Operating Loss Carryforwards, State and Local
Research and development carryforward
Deferred Tax Assets, Tax Credit Carryforwards, Research
Scientific research and experimental development credit carryforward
Deferred Tax Assets, Tax Credit Carryforwards, Scientific Research and Experimental Development
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible scientific research and experimental development tax credit carryforwards.
Stock compensation
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
Foreign NOLs
Deferred Tax Assets, Operating Loss Carryforwards, Foreign
Deferred revenue
Deferred Tax Assets, Deferred Income
Inventory reserves
Deferred Tax Assets, Inventory
Lease liability
Deferred Tax Assets, Operating Lease, Liability
Deferred Tax Assets, Operating Lease, Liability
Other
Deferred Tax Assets, Other
Deferred tax asset
Deferred Tax Assets, Gross
Fixed assets
Deferred Tax Liabilities, Property, Plant and Equipment
Intangible assets
Deferred Tax Liabilities, Intangible Assets
Right-of-use asset
Deferred Tax Liabilities, Leasing Arrangements
Other
Deferred Tax Liabilities, Other
Deferred tax liability
Deferred Tax Liabilities, Gross
Valuation allowance
Deferred Tax Assets, Valuation Allowance
Net deferred tax asset (liability)
Deferred Tax Liabilities, Net
Debt Disclosure [Abstract]
Credit Facility [Axis]
Credit Facility [Axis]
Credit Facility [Domain]
Credit Facility [Domain]
Revolving Credit Facility
Revolving Credit Facility [Member]
Term Loan Facility
Term Loan Facility [Member]
Term loan dated December 2013.
Credit Agreement
Credit Agreement [Member]
Credit agreement dated September 2017.
Amended Credit Agreement
Amended Credit Agreement [Member]
Amended credit agreement dated October 15, 2018.
Variable Rate [Axis]
Variable Rate [Axis]
Variable Rate [Domain]
Variable Rate [Domain]
Federal Funds Rate
Federal Funds Effective Swap Rate [Member]
Eurodollar
Eurodollar [Member]
Base Rate
Base Rate [Member]
Debt Instrument [Line Items]
Number of lending institutions
Number Of Lending Institutions
Number of lending institutions in which the entity has a credit facility.
Current borrowing capacity
Line of Credit Facility, Current Borrowing Capacity
Net leverage ratio
Consolidated Secured, Net Leverage Ratio
Maximum consolidated net leverage ratio required to be maintained under a debt covenant agreement.
Amount required for net leverage ratio
Amount Required for Net Leverage Ratio
Amount of leverage ratio required to be maintained under a debt covenant agreement.
Covenant, leverage ratio
Debt Instrument, Covenant, Leverage Ratio
Maximum leverage ratio required to be maintained under a debt covenant agreement. A leverage ratio is calculated by dividing the funded debt by earnings before interest, taxes, depreciation and amortization for the most recent four quarters.
Debt instrument, basis spread on variable rate
Debt Instrument, Basis Spread on Variable Rate
Outstanding credit facility
Long-term Line of Credit
Debt issuance capitalized costs
Debt Issuance Costs, Line of Credit Arrangements, Net
Debt instrument, term of variable rate
Debt Instrument Term of Variable Rate
Term of the interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.
Commitment fee percentage
Line of Credit Facility, Commitment Fee Percentage
Percentage of original principal amount required to repay in the first two years
Percentage of Original Principal Amount Required to Repay in First Two Years
The rate of interest that was being paid on the original debt issue that is to repay in the first two years.
Percentage of original principal amount required to repay during the third year
Percentage of Original Principal Amount Required to Repay During the Third Year
The rate of interest that was being paid on the original debt issue that is to repay in the third year.
Percentage of original principal amount required to repay remaining year
Percentage of Original Principal Amount Required to Repay Remaining Years
The rate of interest that was being paid on the original debt issue that is to repay in remaining years.
Cash proceeds excess amount from dispositions of property or casualty events subject to certain reinvestment right
Cash Proceeds Excess Amount from Dispositions of Property or Casualty Events Subject to Certain Reinvestment Right
The cash proceeds in excess during the term of the Senior Secured Credit Facility from certain dispositions of property or from casualty events involving their property, subject to certain reinvestment rights.
Debt service coverage ratio
Debt Instrument, Covenant, Debt Service Coverage Ratio
Debt Instrument, Covenant, Debt Service Coverage Ratio
Net leverage ratio one
Debt Covenant, Net Leverage Ratio, One
Maximum leverage ratio required to be maintained under a debt covenant agreement. A leverage ratio is calculated by dividing the funded debt by earnings before interest, taxes, depreciation and amortization for the most recent four quarters.
Debt covenant, leverage ratio from September 30, 2019 to September 29, 2020
Debt Covenant, Net Leverage Ratio, Two
Maximum leverage ratio required to be maintained under a debt covenant agreement. A leverage ratio is calculated by dividing the funded debt by earnings before interest, taxes, depreciation and amortization for the most recent four quarters.
Net leverage ratio three
Debt Covenant, Net Leverage Ratio, Three
Maximum leverage ratio required to be maintained under a debt covenant agreement. A leverage ratio is calculated by dividing the funded debt by earnings before interest, taxes, depreciation and amortization for the most recent four quarters.
Net leverage ratio four
Debt Covenant, Net Leverage Ratio, Four
Maximum leverage ratio required to be maintained under a debt covenant agreement. A leverage ratio is calculated by dividing the funded debt by earnings before interest, taxes, depreciation and amortization for the most recent four quarters.
Debt instrument, restricted payments limit, amount
Debt Instrument, Restricted Payments Limit, Amount
Debt Instrument, Restricted Payments Limit, Amount
Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]
Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]
Derivatives, Fair Value [Line Items]
Derivatives, Fair Value [Line Items]
Reclassification of net deferred losses from accumulated other comprehensive loss
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months
PaxVax
PaxVax [Member]
Business acquisition on October 4, 2018.
Deferred tax assets, net
Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets
Deferred tax assets, measurement period adjustments
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets
Goodwill
Accrued expenses and other liabilities, measurement period adjustment
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses And Other Liabilities
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses And Other Liabilities
Acquired in-process research and development, measurement period adjustment
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Finite-lived Intangible Assets
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Finite-lived Intangible Assets
Leases
Lessee, Operating Leases [Text Block]
Leases
Lessee, Finance Leases [Text Block]
Statement of Comprehensive Income [Abstract]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax
Net income
Net Income (Loss) Attributable to Parent
Other comprehensive income (loss), net of tax:
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Foreign currency translation
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent
Unrealized losses on hedging activities, net of tax
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax
Unrealized losses on hedging activities, net of tax
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax
Unrealized losses on pension benefit obligation, net of tax
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent
Comprehensive income
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax, Attributable to Parent
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax, Attributable to Parent
Purchase Obligation, Fiscal Year Maturity [Abstract]
Total purchase commitment
Purchase Obligation
Purchase commitment period
Long-term Purchase Commitment, Period
Materials purchased under commitment, amount
Long-term Purchase Commitment, Amount
Service cost
Interest cost
Expected return on plan assets
Defined Benefit Plan, Expected Return (Loss) on Plan Assets
Net periodic benefit cost
Defined Benefit Plan, Net Periodic Benefit Cost (Credit)
Disaggregation of Revenue [Table]
Disaggregation of Revenue [Table]
Products and Services [Axis]
Product sales, net
Product [Member]
Contract development and manufacturing services
Contract Manufacturing [Member]
Revenue earned during the period arising from manufacturing sale under the terms of a contract.
Contracts and grants
Contracts and Grants [Member]
Amount of revenue earned from products sold or services provided under the terms of a contract, including, but not limited to, government contracts and grants.
Geographical [Axis]
Geographical [Axis]
Geographical [Domain]
Geographical [Domain]
U.S Government
UNITED STATES
Non-U.S. Government
Non-US [Member]
Disaggregation of Revenue [Line Items]
Disaggregation of Revenue [Line Items]
Total revenues
Revenue from Contract with Customer, Excluding Assessed Tax
Indefinite-lived Intangible Assets [Axis]
Indefinite-lived Intangible Assets [Axis]
Indefinite-lived Intangible Assets, Major Class Name [Domain]
Indefinite-lived Intangible Assets, Major Class Name [Domain]
Number of employees
Number Of Employees
Number of persons employed by the entity
Common stock issued for acquisition (in shares)
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares
Share price (in dollars per share)
Business Acquisition, Share Price
Amount of common stock issued for acquisition including adjustments
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable
Issuance of common stock in acquisition
Stock Issued During Period, Value, Acquisitions
Lock-up period for adjustment of fair value
Lock-up Period for Adjustment of Fair Value
The lock-up period considered for adjustment of fair value, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Remaining consideration payable for acquisition cash amount
Business Combination, Contingent Consideration, Liability, Noncurrent
Amortization period of intangible assets
Finite-Lived Intangible Asset, Useful Life
Present value discount rate
Present Value, Discount Rate
Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure present value. For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt.
Goodwill, impairment loss
Goodwill, Impairment Loss
Statement of Stockholders' Equity [Abstract]
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Award Type [Axis]
Award Type [Axis]
Equity Award [Domain]
Equity Award [Domain]
Employee Stock Option
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend yield
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Expected volatility
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Risk-free interest rate
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Expected average life of options
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term
Summary of Property, Plant and Equipment Useful Lives
Acquisitions
Business Combination Disclosure [Text Block]
Raxibacumab
Raxibacumab [Member]
Raxibacumab [Member]
Upfront payments
Upfront Payments
Refers to upfront payments by the entity.
Amount of payment for manufacturing related milestones
Amount Of Payment For Manufacturing Related Milestones
The cash outflow associated with manufacturing related milestones.
Transaction costs
Business Combination, Acquisition Related Costs
Increase to contingent consideration liability
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]
Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]
Products
Corporate trade name
Trademarks and Trade Names [Member]
Customer relationships
Customer Relationships [Member]
Contract development and manufacturing services
Acquired Finite-Lived Intangible Assets [Line Items]
Acquired Finite-Lived Intangible Assets [Line Items]
Estimated Life
Cost
Finite-Lived Intangible Assets, Gross
Additions
Finite-lived Intangible Assets Acquired
Accumulated Amortization
Finite-Lived Intangible Assets, Accumulated Amortization
Net
Finite-Lived Intangible Assets, Net
Interest expense
Interest Expense [Member]
Hedging Relationship [Axis]
Hedging Relationship [Axis]
Hedging Relationship [Domain]
Hedging Relationship [Domain]
Cash Flow Hedging
Cash Flow Hedging [Member]
Amount of Gain/(Loss) Recognized in OCI on Derivative
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax
Amount of Gain/(Loss) Recognized in OCI on Derivative
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net
Intangible assets and goodwill
Goodwill and Intangible Assets Disclosure [Text Block]
Summary of Significant Components of the Provisions for Income Taxes Attributable to Operations
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
Schedule of Deferred Tax Assets and Liabilities
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
Reconciliation of Income Before the Provision for Income Taxes
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]
Schedule of Unrecognized Tax Benefits Activity
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
Plan Name [Axis]
Plan Name [Axis]
Plan Name [Domain]
Plan Name [Domain]
Emergent Plans
Emergent Plans [Member]
Refers to the Company's two stock-based employee compensation plans, the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan (the "2006 Plan") and the Emergent BioSolutions Employee Stock Option Plan (the "2004 Plan").
Number of stock based employee compensation plans
Number Of Stock-based Employee Compensation Plans
Represents the number of stock-based compensation plans the company maintains.
Exercise period of options
Share Based Compensation Arrangement by Share-based Payment Award, Options, Exercise Period
Represents the period over which options can be exercised from the date of grant.
Quarterly Financial Information Disclosure [Abstract]
Schedule of Quarterly Financial Information
Quarterly Financial Information [Table Text Block]
Statement of Cash Flows [Abstract]
Cash flows from operating activities:
Net Cash Provided by (Used in) Operating Activities [Abstract]
Adjustments to reconcile to net cash provided by operating activities:
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Share-based compensation
Share-based Compensation
Depreciation and amortization
Other Depreciation and Amortization
Deferred income taxes
Deferred Income Tax Expense (Benefit)
Change in fair value of contingent consideration, net
Change In Fair Value Of Contingent Consideration
Fair value measurement of contingent value rights and contingent purchase considerations granted under purchase agreements.
Impairment of IPR&D intangible asset
Impairment of Intangible Assets, Finite-lived
Amortization of deferred financing costs
Amortization of Debt Issuance Costs
Other
Other Noncash Income (Expense)
Changes in operating assets and liabilities:
Increase (Decrease) in Operating Capital [Abstract]
Accounts receivable
Increase (Decrease) in Accounts Receivable
Inventories
Increase (Decrease) in Inventories
Income taxes
Increase (Decrease) in Income Taxes Receivable
Prepaid expenses and other assets
Increase (Decrease) in Prepaid Expense and Other Assets
Accounts payable
Increase (Decrease) in Accounts Payable
Accrued expenses and other liabilities
Increase (Decrease) in Accrued Liabilities
Accrued compensation
Increase (Decrease) in Employee Related Liabilities
Deferred revenue
Increase (Decrease) in Contract with Customer, Liability
Net cash provided by operating activities:
Net Cash Provided by (Used in) Operating Activities
Cash flows from investing activities:
Net Cash Provided by (Used in) Investing Activities [Abstract]
Purchases of property, plant and equipment and other
Payments to Acquire Property, Plant, and Equipment
Milestone payment from asset acquisition
Payments for Previous Acquisition
Asset acquisitions
Payments to Acquire Productive Assets
Business acquisitions, net of cash acquired
Payments to Acquire Businesses, Net of Cash Acquired
Proceeds from sale of assets
Proceeds from Sale of Productive Assets
Net cash used in investing activities:
Net Cash Provided by (Used in) Investing Activities
Cash flows from financing activities:
Net Cash Provided by (Used in) Financing Activities [Abstract]
Proceeds from revolving credit facility
Proceeds from Long-term Lines of Credit
Proceeds from term loan facility
Proceeds from Issuance of Medium-term Notes
Principal payments on revolving credit facility
Repayments of Long-term Lines of Credit
Principal payments on term loan facility
Repayments of Medium-term Notes
Proceeds from issuance of common stock upon exercise of stock options
Proceeds from Stock Options Exercised
Debt issuance costs
Payments of Debt Issuance Costs
Taxes paid on behalf of employees for equity activity
Payments Related to Tax Withholding for Share-based Compensation
Payment of notes payable to Aptevo
Repayments of Notes Payable
Contingent consideration payments
Payment for Contingent Consideration Liability, Financing Activities
Receipts and payments of restricted cash
Proceeds from (Repayments of) Restricted Cash, Financing Activities
Purchase of treasury stock
Payments for Repurchase of Common Stock
Net cash (used in) provided by financing activities
Net Cash Provided by (Used in) Financing Activities
Effect of exchange rate changes on cash and cash equivalents
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Net increase (decrease) in cash and cash equivalents and restricted cash
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Cash and cash equivalents and restricted cash at beginning of year
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Cash and cash equivalents and restricted cash at end of year
Supplemental disclosure of cash flow information:
Supplemental Cash Flow Information [Abstract]
Cash paid during the year for interest
Interest Paid, Excluding Capitalized Interest, Operating Activities
Cash paid during the year for income taxes
Income Taxes Paid
Supplemental information on non-cash investing and financing activities:
Other Noncash Investing and Financing Items [Abstract]
Issuance of common stock to acquire Adapt Pharma
Stock Issued
Purchases of property, plant and equipment unpaid at year end
Capital Expenditures Incurred but Not yet Paid
Reconciliation of cash and cash equivalents and restricted cash:
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value
Restricted cash
Restricted Cash, Current
Total
Revenue, Initial Application Period Cumulative Effect Transition [Table]
Revenue, Initial Application Period Cumulative Effect Transition [Table]
Accounting Standards Update 2014-09
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Change in Contract With Customer, Liability [Roll Forward]
Change in Contract With Customer, Liability [Roll Forward]
Change in Contract With Customer, Liability [Roll Forward]
Beginning balance
Deferral of revenue
Contract with Customer, Liability, Additions
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable recorded during the current reporting period.
Revenue recognized
Contract with Customer, Liability, Revenue Recognized
Ending balance
2020
Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months
2021
Long-term Debt, Maturities, Repayments of Principal in Year Two
2022
Long-term Debt, Maturities, Repayments of Principal in Year Three
2023
Long-term Debt, Maturities, Repayments of Principal in Year Four
2024 and thereafter
Long-term Debt, Maturities, Repayments of Principal in Year Five and Thereafter
Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year and thereafter following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
Total debt
Long-term Debt
Income Tax Contingency [Table]
Income Tax Contingency [Table]
Domestic Tax Authority
Foreign Tax Authority
Foreign Tax Authority [Member]
Tax Credit Carryforward [Axis]
Tax Credit Carryforward [Axis]
Tax Credit Carryforward, Name [Domain]
Tax Credit Carryforward, Name [Domain]
Research Tax Credit Carryforward
Research Tax Credit Carryforward [Member]
Manitoba Scientific Research and Experimental Development
Manitoba Scientific Research And Experimental Development [Member]
Refers to Manitoba Scientific Research And Experimental Development.
Income Tax Contingency [Line Items]
Income Tax Contingency [Line Items]
Federal corporate tax rate
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent
Provisional tax benefit
Tax Cuts And Jobs Act Of2017 Incomplete Accounting Provisional Income Tax Expense Benefit
Amount of reasonable estimate for income tax expense (benefit) from effect of Tax Cuts and Jobs Act of 2017 for which accounting for tax effect is incomplete.
Provisional tax benefit, adjustment
Tax Cuts and Jobs Act of 2017, Measurement Period Adjustment, Income Tax Expense (Benefit)
Amount of income tax expense (benefit) for measurement period adjustment from accounting for tax effect pursuant to Tax Cuts and Jobs Act of 2017.
Estimated undistributed foreign E&P
Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Provisional Undistributed Accumulated Earnings of Foreign Subsidiary
Amount of reasonable estimate for undistributed accumulated earnings of foreign subsidiary intended to be permanently reinvested outside country of domicile for which accounting for tax effect is incomplete pursuant to Tax Cuts and Jobs Act of 2017.
Provisional tax expense
Tax Cuts And Jobs Act Of 2017 Incomplete Accounting Transition Tax For Accumulated Foreign Earnings Provisional Income Tax Expense
Amount of reasonable estimate for income tax expense from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act of 2017 for which accounting for tax effect is incomplete.
Provisional transition tax amount reduction
Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Expense (Benefit)
Amount of reasonable estimate for income tax expense (benefit) for remeasurement of deferred tax from change in tax rate pursuant to Tax Cuts and Jobs Act of 2017 for which accounting for tax effect is incomplete.
Deferred tax liabilities, net
Operating loss carryforwards
Operating Loss Carryforwards
Tax credit carryforward, amount
Tax Credit Carryforward, Amount
Valuation allowance
Tax credit carryforward, valuation allowance
Tax Credit Carryforward, Valuation Allowance
Operating loss carryforwards, valuation allowance
Operating Loss Carryforwards, Valuation Allowance
Effective income tax rate reconciliation, percent
Effective Income Tax Rate Reconciliation, Percent
Unrecognized tax benefits, current
Unrecognized Tax Benefits, Current
The gross amount of unrecognized tax benefits pertaining to uncertain tax positions taken in tax returns, and classified as a current liability as of the balance sheet date.
Unrecognized tax benefits, noncurrent
Unrecognized Tax Benefits, Noncurrent
The gross amount of unrecognized tax benefits pertaining to uncertain tax positions taken in tax returns, and classified as a non-current liability as of the balance sheet date.
Gross unrecognized tax benefits
Unrecognized Tax Benefits
Unrecognized tax benefits acquired in business combinations
Unrecognized Tax Benefits, Increase Resulting from Acquisition
Asset Derivatives
Derivative Asset, Fair Value, Gross Asset
Liability Derivatives
Derivative Liability, Fair Value, Gross Liability
Discount rate
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate
Expected rate of return
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets
Rate of future compensation increases
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase
Total contributions expected
Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year
Vivotif
Vivotif [Member]
This is a live attenuated vaccine for oral administration to prevent typhoid fever.
Vaxchora
Vaxchora [Member]
This is a live attenuated cholera vaccine and the first vaccine approved by the FDA for the prevention of cholera infection
Intangible assets, weighted average useful life
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life
Summary of Lease Expense Cost
Lease, Cost [Table Text Block]
Goodwill [Roll Forward]
Goodwill [Roll Forward]
Goodwill, beginning balance
Goodwill, Gross
Additions
Goodwill, Acquired During Period
Goodwill, ending balance
Statement [Table]
Statement [Table]
$0.001 Par Value Common Stock
Common Stock [Member]
Additional Paid-In Capital
Additional Paid-in Capital [Member]
Treasury Stock
Treasury Stock [Member]
Accumulated Other Comprehensive Loss
Statement [Line Items]
Statement [Line Items]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)
Balance, as adjusted
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance
Employee equity plans activity (in shares)
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures
Employee equity plans activity
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures
Shares issued to extinguish convertible notes (in shares)
Shares issued to extinguish convertible notes
Stock Issued During Period, Value, Conversion of Convertible Securities
Issuance of common stock in acquisitions (in shares)
Stock Issued During Period, Shares, Acquisitions
Treasury stock (in shares)
Treasury Stock, Shares, Acquired
Treasury stock
Treasury Stock, Value, Acquired, Par Value Method
Net income
Other comprehensive income (loss)
Ending balance (in shares)
Schedule of Indefinite-Lived Intangible Assets [Table]
Schedule of Indefinite-Lived Intangible Assets [Table]
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived Intangible Assets [Line Items]
US
Income (Loss) from Continuing Operations before Income Taxes, Domestic
International
Income (Loss) from Continuing Operations before Income Taxes, Foreign
Earnings before taxes on income
Income (Loss) Attributable to Parent, before Tax
Federal tax at statutory rates
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
State taxes, net of federal benefit
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount
Impact of foreign operations
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount
Change in valuation allowance
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount
Tax credits
Effective Income Tax Rate Reconciliation, Tax Credit, Amount
Transition tax
Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act of 2017, Transition Tax on Accumulated Foreign Earnings, Amount
Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to increase (decrease) from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act of 2017.
Change in U.S. tax rate
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount
Stock compensation
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Compensation Cost, Amount
Other differences
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
Return to provision true-ups
Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount
Transaction costs
Effective Income Tax Rate Reconciliation,Transaction Costs
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to transaction costs.
Contingent consideration
Effective Income Tax Rate Reconciliation, Contingent Consideration, Amount
Effective Income Tax Rate Reconciliation, Contingent Consideration, Amount
Compensation limitation
Effective Income Tax Rate Reconciliation, Compensation Limitation, Amount
Effective Income Tax Rate Reconciliation, Compensation Limitation, Amount
FIN 48
Effective Income Tax Rate Reconciliation, Uncertain Tax Positions, Amount
Effective Income Tax Rate Reconciliation, Uncertain Tax Positions, Amount
GILTI, net
Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act of 2017,Global Intangible Low-taxed Income Tax, net
Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to increase (decrease) from Gilti (Global Intangible Low-taxed Income) tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act of 2017.
Permanent differences
Effective Income Tax Rate Reconciliation, Permanent Difference
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to permanent differences.
Total provision for income taxes
Income Tax Expense (Benefit)
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Schedule II - Valuation and Qualifying Accounts
SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]
Earnings per share
Earnings Per Share [Text Block]
Other
Other Long Term Debt Facility [Member]
Other Long Term Debt Facility [Member]
Total debt
Current portion of debt, net of debt issuance costs
Long-term Debt, Current Maturities
Unamortized debt issuance costs
Debt Issuance Costs, Noncurrent, Net
Debt, net of current portion
Long-term Debt, Excluding Current Maturities
Inventories
Inventory Disclosure [Text Block]
Current
Current Income Tax Expense (Benefit), Continuing Operations [Abstract]
Federal
Current Federal Tax Expense (Benefit)
State
Current State and Local Tax Expense (Benefit)
International
Current Foreign Tax Expense (Benefit)
Total current
Current Income Tax Expense (Benefit)
Deferred
Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]
Federal
Deferred Federal Income Tax Expense (Benefit)
State
Deferred State and Local Income Tax Expense (Benefit)
International
Deferred Foreign Income Tax Expense (Benefit)
Total deferred
Deferred Income Tax Expense (Benefit) before purchase price adjustment
The component of income tax expense for the period representing the increase (decrease) in the entity's deferred tax assets and liabilities pertaining to continuing operations before purchase price adjustment.
2020
Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months
2021
Finite-Lived Intangible Assets, Amortization Expense, Year Two
2022
Finite-Lived Intangible Assets, Amortization Expense, Year Three
2023
Finite-Lived Intangible Assets, Amortization Expense, Year Four
2024 and beyond
Finite Lived Intangible Assets Amortization Expense Year Five and After
Amount of amortization expense expected to be recognized during the fifth fiscal year and after following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
Summary of significant accounting policies
Significant Accounting Policies [Text Block]
Common stock, voting rights
Common Stock, Number of Votes Per Common Share
Common Stock, Number of Votes Per Common Share
Common stock authorized for issuance under the plan (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized
Common stock available for future awards (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant
Exercise price of option as percentage of fair market value at grant date, minimum
Exercise Price Of Option As Percentage Of Fair Market Value At Grant Date, Minimum
Minimum exercise price of option as percentage of the fair market value of the shares underlying such option on the date of grant.
Contractual life of awards
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period
Weighted average remaining contractual term of options outstanding
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Weighted average remaining contractual term of options exercisable
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Weighted average grant date fair value of options granted (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Total intrinsic value of options exercised
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Total fair value of awards vested
Share based Compensation Arrangement Share based Payment Award, Awards Vested in Period, Fair Value
Fair value of share-based compensation awards vested. Includes options, share units, stock appreciation rights, and restricted stock.
Compensation cost expected to be recognized related to unvested equity awards
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options
Weighted average period expected to be recognized related to unvested equity awards
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition
Concentration Risk [Table]
Concentration Risk [Table]
Concentration Risk Type [Axis]
Concentration Risk Type [Axis]
Concentration Risk Type [Domain]
Concentration Risk Type [Domain]
Customer Concentration Risk
Customer Concentration Risk [Member]
Accounts Receivable
Accounts Receivable [Member]
Customer [Axis]
Customer [Axis]
Customer [Domain]
Customer [Domain]
USG
United States Government [Member]
United States Government [Member]
Concentration Risk [Line Items]
Concentration Risk [Line Items]
Revenue, remaining performance obligation, amount
Revenue, Remaining Performance Obligation, Amount
Deferred costs, current
Deferred Costs, Current
Matching contributions made by employer
Defined Contribution Plan, Employer Discretionary Contribution Amount
Nature of the business and organization
Nature of Operations [Text Block]
Quarterly financial data (Unaudited)
Quarterly Financial Information [Text Block]
Purchase commitment
Purchase and Supply Commitment, Excluding Long-term Commitment [Text Block]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Antidilutive Securities [Axis]
Antidilutive Securities [Axis]
Antidilutive Securities, Name [Domain]
Antidilutive Securities, Name [Domain]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Numerator:
Net Income (Loss) Available to Common Stockholders, Basic [Abstract]
Interest expense, net of tax
Interest on Convertible Debt, Net of Tax
Amortization of debt issuance costs, net of tax
Amortization of issuance cost on convertible debt net of tax
The after-tax amount of amortization of issuance costs recognized in the period associated with any convertible debt.
Net income, adjusted
Adjusted net loss
The portion of profit or loss for the period, net of income taxes and other adjustments.
Denominator:
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]
Weighted-average number of shares - basic (in shares)
Weighted Average Number of Shares Outstanding, Basic
Dilutive securities-equity awards (in shares)
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements
Dilutive securities-convertible debt (in shares)
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities
Weighted-average number of shares-diluted (in shares)
Weighted Average Number of Shares Outstanding, Diluted
Net income per share-basic (in dollars per share)
Earnings Per Share, Basic
Net income per share-diluted (in dollars per share)
Earnings Per Share, Diluted
Antidilutive shares excluded from calculation (in shares)
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Revenue
Income (loss) from operations
Gross Profit
Net income (loss) per share-diluted (in dollar per share)
Revenue, remaining performance obligation, expected timing of satisfaction, period
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Schedule of Derivative Instruments
Schedule of Derivative Instruments [Table Text Block]
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]
Derivative Instruments, Gain (Loss)
Derivative Instruments, Gain (Loss) [Table Text Block]
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]
SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]
SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]
SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]
SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]
Inventory allowance
SEC Schedule, 12-09, Reserve, Inventory [Member]
Prepaid expenses and other current assets allowance
SEC Schedule, 12-09, Allowance, Prepaid Expenses And Other Current Assets [Member]
A valuation allowance relating to prepaid expenses and other current assets.
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Beginning Balance
SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount
Additions from Acquisition
SEC Schedule, 12-09, Valuation Allowances and Reserves, Business Acquired
Charged to costs and expenses
SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense
Deductions
SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction
Ending Balance
Property, Plant and Equipment [Table]
Property, Plant and Equipment [Table]
Property, Plant and Equipment, Type [Axis]
Property, Plant and Equipment, Type [Axis]
Property, Plant and Equipment, Type [Domain]
Property, Plant and Equipment, Type [Domain]
Land and improvements
Land and Land Improvements [Member]
Buildings, building improvements and leasehold improvements
Building and Building Improvements [Member]
Furniture and equipment
Furniture and Fixtures [Member]
Software
Computer Software, Intangible Asset [Member]
Construction-in-progress
Construction in Progress [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross
Property, Plant and Equipment, Gross
Less: Accumulated depreciation and amortization
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Total property, plant and equipment, net
Property, Plant and Equipment, Net
Depreciation and amortization
Depreciation, Depletion and Amortization
Cover page.
Document Type
Document Type
Document Annual Report
Document Annual Report
Document Period End Date
Document Period End Date
Document Transition Report
Document Transition Report
Entity File Number
Entity File Number
Entity Registrant Name
Entity Registrant Name
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Entity Tax Identification Number
Entity Tax Identification Number
Entity Address, Address Line One
Entity Address, Address Line One
Entity Address, City or Town
Entity Address, City or Town
Entity Address, State or Province
Entity Address, State or Province
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
City Area Code
City Area Code
Local Phone Number
Local Phone Number
Title of 12(b) Security
Title of 12(b) Security
Security Exchange Name
Security Exchange Name
Entity Well-known Seasoned Issuer
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Voluntary Filers
Entity Current Reporting Status
Entity Current Reporting Status
Entity Interactive Data Current
Entity Interactive Data Current
Entity Filer Category
Entity Filer Category
Entity Small Business
Entity Small Business
Entity Emerging Growth Company
Entity Emerging Growth Company
Entity Shell Company
Entity Shell Company
Entity Public Float
Entity Public Float
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference
Documents Incorporated by Reference [Text Block]
Entity Central Index Key
Entity Central Index Key
Current Fiscal Year End Date
Current Fiscal Year End Date
Amendment Flag
Amendment Flag
Document Fiscal Year Focus
Document Fiscal Year Focus
Document Fiscal Period Focus
Document Fiscal Period Focus
Trading Symbol
Trading Symbol
Segment information
Segment Reporting Disclosure [Text Block]
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Gross unrecognized tax benefits, beginning balance
Increases for tax positions for prior years
Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions
Decreases for tax positions for prior years
Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
Increases for tax positions for current year
Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
Settlements
Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities
Lapse of statute of limitations
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
Gross unrecognized tax benefits, ending balance
Defined benefit and 401(k) savings plan
Pension and Other Postretirement Benefits Disclosure [Text Block]
Term of contract under acquisition
Term of Contract Under Acquisition
Term of contract under acquisition.
Value of contract
Value of Contract
Refers to the value of contract.
Amount for deliveries of product
Amount for Deliveries of Product
Amount for deliveries of product to the Strategic National Stockpile ("SNS").
Cash
Amount of payment for regulatory related milestones
Amount Of Payment For Regulatory Related Milestones
The cash outflow associated with regulatory related milestones.
Revenue from Contract with Customer
Revenue from Contract with Customer [Member]
Summary of Reconciliation of Contingent Consideration Liabilities Measured at Fair Value
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Buildings
Building [Member]
Building improvements
Building Improvements [Member]
Software product life
Estimated useful lives
Property, Plant and Equipment, Estimated Useful Lives
2006 Stock Incentive Plan
Emergent BioSolutions Inc. 2006 Stock Incentive Plan [Member]
A share-based compensation plan adopted by the Company in 2006.
Performance Shares
Performance Shares [Member]
Restricted Stock Units (RSUs)
Restricted Stock Units (RSUs) [Member]
Number of Shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding, beginning of period (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Stock options granted (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
Exercised (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
Forfeited (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
Outstanding, end of period (in shares)
Exercisable, end of period (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Weighted-Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Outstanding, beginning of period (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Stock options grant price (in dollars per share)
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Exercised (in dollars per share)
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Forfeited (in dollars per share)
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Outstanding, end of period (in dollars per share)
Exercisable, end of period (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Aggregate Intrinsic Value
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Outstanding
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Exercisable
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
Number of Shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Outstanding, beginning of period (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Restricted stock units granted (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
Vested (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
Forfeited (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Outstanding, end of period (in shares)
Weighted-Average Grant Price
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Outstanding, beginning of period (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Restricted stock units grant price (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Vested (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Forfeited (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Outstanding, end of period (in dollars per share)
Aggregate Intrinsic Value
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract]
Outstanding
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding
United States
Non-US
Geographic Concentration Risk
Geographic Concentration Risk [Member]
Product Concentration Risk
Product Concentration Risk [Member]
BioThrax
Number of reportable segments
Number of Reportable Segments
Assets
Long-Lived Assets
Basis of presentation and consolidation
Consolidation, Policy [Policy Text Block]
Use of estimates
Use of Estimates, Policy [Policy Text Block]
Cash and cash equivalents and restricted cash
Cash and Cash Equivalents, Policy [Policy Text Block]
Fair value measurements
Fair Value Measurement, Policy [Policy Text Block]
Significant customers and accounting receivable
Major Customers, Policy [Policy Text Block]
Concentration risk
Concentrations Risk [Policy Text Block]
Disclosure of accounting policy for concentrations risk.
Inventories
Inventory, Policy [Policy Text Block]
Property, plant and equipment
Property, Plant and Equipment, Policy [Policy Text Block]
Income taxes
Income Tax, Policy [Policy Text Block]
Acquisitions
In Process Research and Development, Policy [Policy Text Block]
Asset impairment analysis
Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]
Contingent consideration
Contingent Consideration Obligations [Policy Text Block]
Disclosure of accounting policy for contingent consideration obligations.
Revenue recognition
Revenue from Contract with Customer [Policy Text Block]
Research and development
Research and Development Expense, Policy [Policy Text Block]
Comprehensive income
Comprehensive Income, Policy [Policy Text Block]
Translation of foreign currencies
Foreign Currency Transactions and Translations Policy [Policy Text Block]
Earnings per share
Earnings Per Share, Policy [Policy Text Block]
Accounting for stock-based compensation
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]
Pension plans
Pension and Other Postretirement Plans, Pensions, Policy [Policy Text Block]
Recently issued accounting standards
New Accounting Pronouncements, Policy [Policy Text Block]
Schedule of Debt
Schedule of Debt [Table Text Block]
Summary of Future Debt Payments of Long-Term Indebtedness
Schedule of Long-term Debt Instruments [Table Text Block]
Equity
Adjustments
Operating lease cost:
Finance Lease, Cost [Abstract]
Amortization of right-of-use assets
Finance Lease, Right-of-Use Asset, Amortization
Interest on lease liabilities
Finance Lease, Interest Expense
Total operating lease cost
Lease, Cost
Operating lease cost
Operating Leases, Rent Expense
Schedule of Inventories
Schedule of Inventory, Current [Table Text Block]
Schedule of Finite-Lived Intangible Assets
Schedule of Finite-Lived Intangible Assets [Table Text Block]
Summary of Future Amortization Expense
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
Summary of Goodwill
Schedule of Goodwill [Table Text Block]
Long-term debt
Debt Disclosure [Text Block]
Income Statement [Abstract]
Contract development and manufacturing services
Contract Development And Manufacturing [Member]
Contract Development And Manufacturing [Member]
Revenues:
Revenues [Abstract]
Operating expenses:
Operating Expenses [Abstract]
Cost of product sales and contract development and manufacturing services
Cost of Goods and Services Sold
Research and development
Research and Development Expense
Selling, general and administrative
Selling, General and Administrative Expense
Amortization of intangible assets
Amortization of Intangible Assets
Total operating expenses
Operating Expenses
Income from operations
Operating Income (Loss)
Other income (expense):
Nonoperating Income (Expense) [Abstract]
Interest expense
Interest Expense
Other income (expense), net
Other Nonoperating Income (Expense)
Total other income (expense), net
Nonoperating Income (Expense)
Income before provision for income taxes
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest
Provision for income taxes
Weighted-average number of shares - diluted (in shares)
ASSETS
Assets [Abstract]
Current assets:
Assets, Current [Abstract]
Accounts receivable, net
Inventories
Income tax receivable, net
Income Taxes Receivable, Current
Prepaid expenses and other current assets
Prepaid Expense and Other Assets, Current
Total current assets
Assets, Current
Property, plant and equipment, net
Intangible assets, net
Intangible Assets, Net (Excluding Goodwill)
In-process research and development
In Process Research And Development
Carrying amount of purchased research and development assets acquired in a business combination that have an indefinite life until completion or abandonment of the associated research and development efforts.
Deferred tax assets, net
Deferred Income Tax Assets, Net
Other assets
Other Assets, Noncurrent
Total assets
Assets
LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities and Equity [Abstract]
Current liabilities:
Liabilities, Current [Abstract]
Accounts payable
Accounts Payable, Current
Accrued expenses
Accrued Liabilities, Current
Accrued compensation
Employee-related Liabilities, Current
Debt, current portion
Notes Payable, Current
Contingent consideration, current portion
Contingent Consideration Current Portion
Carrying value as of the balance sheet date of the current portion of liabilities incurred and payable to former shareholders and stock option holders for certain developmental, regulatory or commercial milestones.
Other current liabilities
Other Liabilities, Current
Total current liabilities
Liabilities, Current
Contingent consideration, net of current portion
Contingent Consideration Net Of Current Portion
Carrying value as of the balance sheet date of the noncurrent portion of liabilities incurred and payable to former shareholders and stock option holders for certain developmental, regulatory or commercial milestones.
Debt, net of current portion
Deferred tax liability
Deferred Income Tax Liabilities, Net
Contract liabilities, net of current portion
Contract with Customer, Liability, Noncurrent
Other liabilities
Other Liabilities, Noncurrent
Total liabilities
Liabilities
Stockholders’ equity:
Stockholders' Equity Attributable to Parent [Abstract]
Preferred stock, $0.001 par value; 15.0 shares authorized, 0 shares issued and outstanding at both December 31, 2019 and 2018
Preferred Stock, Value, Issued
Common stock, $0.001 par value; 200.0 shares authorized, 52.9 shares issued and 51.7 shares outstanding at December 31, 2019; 52.4 shares issued and 51.2 shares outstanding at December 31, 2018
Common Stock, Value, Issued
Treasury stock, at cost, 1.2 common shares at December 31, 2019 and 2018
Treasury Stock, Value
Additional paid-in capital
Additional Paid in Capital
Accumulated other comprehensive loss, net
Accumulated Other Comprehensive Income (Loss), Net of Tax
Retained earnings
Retained Earnings (Accumulated Deficit)
Total stockholders’ equity
Total liabilities and stockholders’ equity
Liabilities and Equity
Schedule of Product Sales
Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]
Face amount
Debt Instrument, Face Amount
Conversion rate of notes per $1,000 principal amount (in shares)
Debt Instrument, Number Of Equity Instruments
Debt Instrument, Number Of Equity Instruments
Debt issuance costs
Debt Issuance Costs, Net
Additional conversion rate of notes per $1,000 principal amount (in shares)
Debt Instrument Number Of Additional Equity Instruments
The number of additional equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.
Accrued interest on converted notes
Debt Instrument Accrued interest on converted notes
Amount for accrued, but unpaid interest on the converted notes for the period.